Saitama, Japan

Dai Kawamura

USPTO Granted Patents = 2 

Average Co-Inventor Count = 1.5

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Tokyo, JP (2015)
  • Saitama, JP (2019)

Company Filing History:


Years Active: 2015-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dai Kawamura: Innovator in Pharmaceutical Composition

Introduction

Dai Kawamura is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance the stability and efficacy of active ingredients.

Latest Patents

Kawamura holds 2 patents, with his latest inventions focusing on innovative pharmaceutical compositions. One of his patents involves a pharmaceutical composition comprising rapamycin or a derivative thereof, aimed at suppressing the reduction of active ingredients caused by oxidation or decomposition. This invention ensures long-term stability and high safety by incorporating trehalose into the composition. Another patent details a polymer derivative of a cytidine metabolic antagonist, designed to release medication irrespective of the body's enzymes, thereby enhancing therapeutic effects.

Career Highlights

Dai Kawamura is associated with Nippon Kayaku Kabushiki Kaisha, a company known for its advancements in pharmaceutical research and development. His work has contributed to the company's reputation for innovation in the industry.

Collaborations

Kawamura collaborates with talented coworkers, including Keiichirou Yamamoto and Manami Okazaki, who share his commitment to advancing pharmaceutical technologies.

Conclusion

Dai Kawamura's innovative work in pharmaceutical compositions demonstrates his dedication to improving medication stability and efficacy. His contributions are significant in the field of pharmaceuticals, showcasing the importance of research and development in enhancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…